Market revenue in 2023 | USD 187.6 million |
Market revenue in 2030 | USD 450.1 million |
Growth rate | 13.3% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 51.12% in 2023. Horizon Databook has segmented the France neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing number of people suffering from obesity & depression is expected to boost the demand for neurostimulation devices. According to the preliminary results of the 2014 European Health Interview Survey, published in Questions d’économie de la santé n 223 in 2017, nearly one third of the population aged 15 years or above in the country rated their health as fair, poor, and very poor.
As per the survey, 46% of population was overweight, and one in ten women had depressive symptoms. Moreover, people suffering from health disorders are more prone to depression. Thus, these factors are driving market growth in France.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account